DrugPatentWatch Database Preview
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
« Back to Dashboard
Tartaric acid is an investigational drug.
There have been 9 clinical trials for Tartaric acid. The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2019.
The most common disease conditions in clinical trials are Lymphoma, Mantle-Cell, Lymphoma, B-Cell, and Venous Thromboembolism. The leading clinical trial sponsors are Boehringer Ingelheim, Population Health Research Institute, and Shiraz University of Medical Sciences.
Recent Clinical Trials for Tartaric acid
|A Study on the Impact of Rabeprazole-induced Elevated Stomach pH on APO-Dabigatran Exposure in Healthy Volunteers||Population Health Research Institute||Phase 4|
|This Study Tests How Different Doses of BI 1291583 Are Taken up in the Body and How Well They Are Tolerated||Boehringer Ingelheim||Phase 1|
|The Effects of Rhus Coriaria L. on Serum Uric Acid Levels||Shiraz University of Medical Sciences||N/A|